CERENOME, INC. - 8-K Filing

Cerenome reports interim ReSPECT-LM data showing no dose-limiting toxicities and early disease control for REYOBIQ™ in leptomeningeal metastases patients. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PSTV

Read the full article at SEC EDGAR

More Regulatory news